996热re视频精品视频这里,国产又色又爽又高潮免费,精品自拍亚洲一区在线,久久久综合九色合综,国产精品亚洲综合一区在线观看

Basic Info

  • Grade: pharmaceutical grade

    Factory Location: Shanghai

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Bugatinib is an oral inhibitor of receptor tyrosine kinase asexual lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR), with potential anti-tumor activity. Bugatinib binds and inhibits ALK kinase and ALK fusion protein, as well as EGFR and mutants. This leads to inhibition of ALK kinase and EGFR kinase, disrupting their signaling pathways and ultimately inhibiting the growth of susceptible tumor cells. In addition, AP26113 seems to be able to overcome mutation based resistance. ALK belongs to the insulin receptor superfamily and plays an important role in the development of the nervous system; ALK dysregulation and gene rearrangement are associated with a range of tumors. EGFR is overexpressed in various types of cancer cells.
Send your message to this supplier
  • From:
  • To:
    Shanghai Hope-chem Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service